CARISMA Therapeutics to Participate in Upcoming Investor Conferences - Oct 05, 2020

PHILADELPHIA, Oct. 5, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual investor conferences in October 2020.

About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

For more information, please visit

Media Contact:
Christina Khoury-Folkens

View original content to download multimedia:

SOURCE CARISMA Therapeutics Inc.

Back to news